Quercetin Inhibit Human SW480 Colon Cancer Growth in Association with Inhibition of Cyclin D₁ and Survivin Expression through Wnt/β-Catenin Signaling Pathway

REFERENCES

• Cadigan K. M., Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997; 11: 3286–3305
   PubMed Web of Science ®Google Scholar
• Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus. Science 2000; 287: 1606–1609
   PubMed Web of Science ®Google Scholar
• Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837–1851
   PubMed Web of Science ®Google Scholar
• Mareel M., Boterberg T., Noe V., Van Hoorde L., Vermeulen S., Bruyneel E., Bracke M. E-cadherin/catenin/cytoskeleton complex: a regulator of cancer invasion. J Cell Physiol 1997; 173: 271–274
   PubMed Web of Science ®Google Scholar
• Bullions L. C., Levine A. J. The role of β-catenin in cell adhesion, signal transduction, and cancer. Curr Opin Oncol 1998; 10: 81–87
   PubMedGoogle Scholar
• He T. C., Sparks A. B., Rago C., Hermeking H., Zawel L., daCosta L., Morin P. J., Vogelstein B., Kinzler K. Identifcation of c-MYC as a target of the APC pathway. Science 1998; 281: 1509–1512
   PubMed Web of Science ®Google Scholar
• Tetsu O., McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422–426
   PubMed Web of Science ®Google Scholar
• Mann B., Gelos M., Siedow A., Hanski M. L., Gratchev A., Ilyas M., Bodmer W. F., Moyer M. P., Riecken E. O., Buhr H. J., Hanski C. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999; 96: 1603–1608
   PubMed Web of Science ®Google Scholar
• Rubinfeld B., Albert I., Porri E., Fiol C., Munemitsu S., Polakis P. Binding of GSK3βto the APC–β-catenin complex and regulation of complex assembly. Science 1996; 272: 1023–1026
   PubMed Web of Science ®Google Scholar
• Morin P. J., Sparks A. B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275: 1787–1790
   PubMed Web of Science ®Google Scholar
• Fujie H., Moriya K., Shintani Y., Tsutsumi T., Takayama T., Makuuchi M., Kimura S., Koike K. Frequent β-catenin aberration in human hepatocellular carcinoma. Hepatol Res 2001; 20: 39–51
   PubMed Web of Science ®Google Scholar
• Woo D. K., Kim H. S., Lee H. S., Kang Y. H., Yang H. K., Kim W. H. Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001; 95: 108–113
   PubMed Web of Science ®Google Scholar
• Sparks A. B., Morin P. J., Vogelstein B., Kinzler K. W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998; 58: 1130–1134
   PubMed Web of Science ®Google Scholar
• Bright-Thomas R. M., Hargest R. APC, β-catenin, and hTCF-4: an unholy trinity in the genesis of colorectal cancer. Eur J Surg Oncol 2003; 29: 107–117
   PubMedGoogle Scholar
• Matsukawa Y., Nishino H., Okuyama Y., Matsui T., Matsumoto T., Matsumura S., Shimizu Y., Sowa Y., Sakai T. Effects of quercetin and/or restraint stress on formation of aberrant crypt foci induced by azoxymethane in rat colons. Oncology 1997; 54: 118–121
   PubMed Web of Science ®Google Scholar
• Kuo S. M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 1996; 110: 41–48
   PubMed Web of Science ®Google Scholar
• Agullo G., Gamet Payrastre L., Fernandez Y., Anciaux N., Demigne C., Remsey C. Comparative effects of flavonoids on the growth, viability, and metabolism of a colonic adenocarcinoma cell line (HT29 cells). Cancer Lett 1996; 105: 61–70
   PubMed Web of Science ®Google Scholar
• Tetsu O., McCormick F. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell 2003; 3: 233–245
   PubMed Web of Science ®Google Scholar
• Ma H., Nguyen C., Lee K. S., Kahn M. Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression. Oncogene 2005; 24: 3619–3631
   PubMed Web of Science ®Google Scholar
• Harborne J. B., Williams C. A. Advances in flavonoid research since 1992. Phytochemistry 2000; 55: 481–504
   PubMed Web of Science ®Google Scholar
• Kandaswami C., Middleton E. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 1994; 366: 351–376
   PubMedGoogle Scholar
• Webber M., Bello D., Quader S. Immortalized and tumorigenic adult human prostatic epithelian cell lines: characteristics and applications. Part 2. Tumorigenic cell lines. Prostate 1997; 30: 58–64
   PubMed Web of Science ®Google Scholar
• Deschner E. E., Ruperto J. F., Wong G. Y., Newmark H. L. The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer 1993; 20: 199–204
   PubMed Web of Science ®Google Scholar
• Yang J. H., Hsia T. C.l., Kuo H. M., Lee Chao P. D., Chou C. C., Wei Y. H., Chung J. G. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 2006; 34: 296–304
   PubMed Web of Science ®Google Scholar
• Yoshida M., Sakai T., Hosokawa N., Nikaido T. Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 1992; 52: 6676–6681
   PubMed Web of Science ®Google Scholar
• Hosokawa N., Hosokawa Y., Sakai T., Yoshida M., Marui N., Nishino H., Kawai K., Aoike A. Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein in human colon cancer cells. Int J Cancer 1990; 45: 1119–1124
   PubMed Web of Science ®Google Scholar
• Wang W., VanAlstyne P. C., Irons K. A., Chen S., Stewart J. W., Birt D. F. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines. Nutr Cancer 2004; 48: 106–114
   PubMed Web of Science ®Google Scholar
• Petru E., Sevin B. U., Haas J., Ramos R., Perras J. A correlation of cell cycle perturbations with chemosensitivity in human ovarian cancer cells exposed to cytotoxic drugs in vitro. Gynecol Oncol 1995; 58: 48–57
   PubMed Web of Science ®Google Scholar
• Iwao K., Tsukamotol I. Quercetin inhibited DNA synthesis and induced apoptosis associated with increase in c-fos mRNA level and the upregulation of p21WAF1CIP1 mRNA and protein expression during liver regeneration after partial hepatectomy. Biochem Biophys Acta 1999; 1427: 112–120
   PubMed Web of Science ®Google Scholar
• Pawlikowska-Pawlega B., Jakubowicz-Gil J., Rzymowska J., Gawron A. The effect of quercetin on apoptosis and necrosis induction in human colon adenocarcinoma cell line LS180. Folia Histochem Cytobiol 2001; 39: 217–218
   PubMed Web of Science ®Google Scholar
• Yang K., Lamprecht S. A., Liu Y., Shinozaki H., Fan K., Leung D., Newmark H., Steele V. E., Kelloff G. J., Lipkin M. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 2000; 21: 1655–1660
   PubMed Web of Science ®Google Scholar
• Wei Y. Q., Zhao X., Kariya Y., Fukata H., Teshigawara K., Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 1994; 54: 4952–4957
   PubMed Web of Science ®Google Scholar
• Nagasaka Y., Nakamura K. Modulation of the heat-induced activation of mitogen-activated protein (MAP) kinase by quercetin. Biochem Pharmacol 1998; 56: 1151–1155
   PubMed Web of Science ®Google Scholar
• Dashwood W. M., Orner G. A., Dashwood R. H. Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H2O2 at physiologically relevant EGCG concentrations. Biochem Biophys Res Commun 2002; 296: 584–588
   PubMed Web of Science ®Google Scholar
• Jaiswal A. S., Marlow B. P., Gupta N., Narayan S. β-Catenin mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 2002; 21: 8414–8427
   PubMed Web of Science ®Google Scholar
• Orner G. A., Dashwood W. M., Blum C. A., Diaz G. D., Li Q., Dashwood R. H. Suppression of tumorigenesis in the Apcmin mouse: downregulation of β-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 2003; 24: 263–267
   PubMed Web of Science ®Google Scholar
• Kim W. K., Bang M. H., Kim E. S., Kang N. E., Jung K. C., Cho H. J., Park J. H. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem 2005; 16: 155–162
   PubMed Web of Science ®Google Scholar
• Yuan Z. P., Chen L. J., Fan L. Y., Tang M. H., Yang G. L., Yang H. S., Du X. B., Wang G. Q., Yao W. X., Zhao Q. M., Ye B., Wang R., Diao P., Zhang W., Wu H. B., Zhao X., Wei Y. Q. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res. 2006; 12: 3193–3199
   PubMed Web of Science ®Google Scholar
• Ferry D. R., Smith A., Malkhandi J., Fyfe D. W., Detakats P. G., Anderson D., Baker J., Kerr D. J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence forin vivo tyrosine kinase inhibition. Clin Cancer Res 1996; 2: 659–668
   PubMed Web of Science ®Google Scholar